Douglas Maffei

Douglas Maffei, Ph.D., is a dynamic and results-driven leader in biopharmaceutical corporate communications and investor relations. They have extensive experience leading strategic investor relations, communications, and ESG initiatives, significantly enhancing company valuations and reputations. Their recent roles include Vice President of Investor Relations at Pfizer and Seagen, where they shaped investor narratives and guided major acquisitions. A graduate of the McKinsey & Company Executive Leadership Program, they hold a Ph.D. in Molecular Genetics and Biochemistry from Royal Holloway, University of London.